Quest Diagnostics Incorporated Stock Revenue
| DGX Stock | USD 125.91 1.07 0.84% |
Quest Diagnostics Incorporated fundamentals help investors to digest information that contributes to Quest Diagnostics' financial success or failures. It also enables traders to predict the movement of Quest Stock. The fundamental analysis module provides a way to measure Quest Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Quest Diagnostics stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 9.3 B | 6.9 B |
Quest | Revenue |
Quest Diagnostics Incorporated Company Revenue Analysis
Quest Diagnostics' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Quest Diagnostics Revenue | 9.25 B |
Most of Quest Diagnostics' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Quest Diagnostics Incorporated is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Quest
Projected quarterly revenue analysis of Quest Diagnostics provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Quest Diagnostics match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Quest Diagnostics' stock price.
Quest Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for Quest Diagnostics is extremely important. It helps to project a fair market value of Quest Stock properly, considering its historical fundamentals such as Revenue. Since Quest Diagnostics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Quest Diagnostics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Quest Diagnostics' interrelated accounts and indicators.
| -0.52 | -0.57 | 0.56 | -0.75 | -0.19 | ||
| -0.52 | 0.99 | 0.03 | 0.83 | 0.86 | ||
| -0.57 | 0.99 | -0.08 | 0.84 | 0.82 | ||
| 0.56 | 0.03 | -0.08 | -0.25 | 0.17 | ||
| -0.75 | 0.83 | 0.84 | -0.25 | 0.61 | ||
| -0.19 | 0.86 | 0.82 | 0.17 | 0.61 |
Click cells to compare fundamentals
Quest Revenue Historical Pattern
Today, most investors in Quest Diagnostics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Quest Diagnostics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Quest Diagnostics revenue as a starting point in their analysis.
Quest Diagnostics Revenue |
| Timeline |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Quest Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Quest Diagnostics Incorporated reported 9.25 B of revenue. This is 21.31% higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The revenue for all United States stocks is 1.94% higher than that of the company.
Quest Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Quest Diagnostics' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Quest Diagnostics could also be used in its relative valuation, which is a method of valuing Quest Diagnostics by comparing valuation metrics of similar companies.Quest Diagnostics is currently under evaluation in revenue category among related companies.
Quest Diagnostics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Quest Diagnostics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Quest Diagnostics' managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Quest Diagnostics Institutional Holders
Institutional Holdings refers to the ownership stake in Quest Diagnostics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Quest Diagnostics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Quest Diagnostics' value.| Shares | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 1.9 M | Amvescap Plc. | 2023-12-31 | 1.7 M | Grantham, Mayo, Van Otterloo & Co., Llc | 2023-12-31 | 1.7 M | Wells Fargo & Co | 2023-12-31 | 1.5 M | Fmr Inc | 2023-12-31 | 1.3 M | Northern Trust Corp | 2023-12-31 | 1.1 M | Bank Of America Corp | 2023-12-31 | 1 M | Legal & General Group Plc | 2023-12-31 | 1 M | Ameriprise Financial Inc | 2023-12-31 | 1 M | Vanguard Group Inc | 2023-12-31 | 13.6 M | Blackrock Inc | 2023-12-31 | 10.6 M |
Quest Fundamentals
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0621 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 18.86 B | ||||
| Shares Outstanding | 111.06 M | ||||
| Shares Owned By Insiders | 0.43 % | ||||
| Shares Owned By Institutions | 91.74 % | ||||
| Number Of Shares Shorted | 2.55 M | ||||
| Price To Earning | 14.57 X | ||||
| Price To Book | 2.26 X | ||||
| Price To Sales | 1.54 X | ||||
| Revenue | 9.25 B | ||||
| Gross Profit | 3.47 B | ||||
| EBITDA | 1.26 B | ||||
| Net Income | 850 M | ||||
| Cash And Equivalents | 315 M | ||||
| Cash Per Share | 6.15 X | ||||
| Total Debt | 5.37 B | ||||
| Debt To Equity | 0.73 % | ||||
| Current Ratio | 1.46 X | ||||
| Book Value Per Share | 56.82 X | ||||
| Cash Flow From Operations | 1.27 B | ||||
| Short Ratio | 2.81 X | ||||
| Earnings Per Share | 7.49 X | ||||
| Price To Earnings To Growth | 1.52 X | ||||
| Target Price | 142.29 | ||||
| Number Of Employees | 40 K | ||||
| Beta | 0.89 | ||||
| Market Capitalization | 13.98 B | ||||
| Total Asset | 14.02 B | ||||
| Retained Earnings | 8.82 B | ||||
| Working Capital | 557 M | ||||
| Current Asset | 1.5 B | ||||
| Current Liabilities | 1.17 B | ||||
| Annual Yield | 0.02 % | ||||
| Five Year Return | 1.89 % | ||||
| Net Asset | 14.02 B | ||||
| Last Dividend Paid | 2.84 |
About Quest Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Quest Diagnostics Incorporated's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Quest Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Quest Diagnostics Incorporated based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Quest Diagnostics Investors Sentiment
The influence of Quest Diagnostics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Quest. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Quest Diagnostics' public news can be used to forecast risks associated with an investment in Quest. The trend in average sentiment can be used to explain how an investor holding Quest can time the market purely based on public headlines and social activities around Quest Diagnostics Incorporated. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Quest Diagnostics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Quest Diagnostics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Quest Diagnostics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Quest Diagnostics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Quest Diagnostics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Quest Diagnostics' short interest history, or implied volatility extrapolated from Quest Diagnostics options trading.
Pair Trading with Quest Diagnostics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Quest Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quest Diagnostics will appreciate offsetting losses from the drop in the long position's value.Moving against Quest Stock
| 0.6 | TIL | Instil Bio Financial Report 9th of May 2024 | PairCorr |
| 0.42 | EWTX | Edgewise Therapeutics Financial Report 9th of May 2024 | PairCorr |
The ability to find closely correlated positions to Quest Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Quest Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Quest Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Quest Diagnostics Incorporated to buy it.
The correlation of Quest Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Quest Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Quest Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Quest Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Quest Diagnostics Piotroski F Score and Quest Diagnostics Altman Z Score analysis. Note that the Quest Diagnostics information on this page should be used as a complementary analysis to other Quest Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Quest Stock analysis
When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |
Is Quest Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quest Diagnostics. If investors know Quest will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quest Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.868 | Dividend Share 2.84 | Earnings Share 7.49 | Revenue Per Share 82.607 | Quarterly Revenue Growth (0.02) |
The market value of Quest Diagnostics is measured differently than its book value, which is the value of Quest that is recorded on the company's balance sheet. Investors also form their own opinion of Quest Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Quest Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quest Diagnostics' market value can be influenced by many factors that don't directly affect Quest Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quest Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Quest Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quest Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.